First Generic Version of Viagra Clears FDA

Megan Brooks


March 11, 2016

The US Food and Drug Administration (FDA) has approved the first generic version of Pfizer's erectile dysfunction drug Viagra (sildenafil citrate), according to multiple media reports.

The generic version will be available starting December 11, 2017, according to manufacturer Teva Pharmaceuticals. Generic sildenafil citrate will be available in 25-, 50-, and 100-mg pills.

Pfizer's Viagra does not lose patent protection until 2020, but Pfizer reached a settlement with Teva in December 2013 allowing Teva to launch its generic version in 2017.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: